Key Market Insights
- Presently, close to 85 players are offering biopharmaceutical filtration systems across the globe; of these, over 80% companies claim to have the capability to develop membrane filters for a wide range of application areas
- The biopharmaceutical filtration systems market is primarily characterized by the presence of well-established players; of these, over 75% firms develop systems for cell separation and product purification
- In pursuit of gaining a competitive edge, stakeholders are actively upgrading existing capabilities and enhancing their respective offerings to comply with the evolving industry benchmarks
- In the last five years, more than 125 patents related to biopharmaceutical filtration have been granted to various industry and non-industry stakeholders
- Given the rising demand for biologics, stakeholders are actively establishing themselves as one-stop-shops, by consolidating their capabilities, related to biopharmaceutical filtration, via mergers and acquisitions
- Both industry and non-industry players have participated in various global events to demonstrate the ongoing research outcomes, affiliated challenges, as well as opportunities in the biopharmaceutical filtration industry
- The biopharmaceutical filtration market is projected to grow at a CAGR of ~10%, till 2035; the forecasted opportunity is likely to be distributed across different types of filtration systems and filter assemblies
- In the long-term, majority share of the revenues is likely to be generated from single-use technologies; North America is anticipated to capture a relatively larger proportion of the overall market, by 2035
It is a critical step in the manufacturing process of biopharmaceutical products, and its applications are essential in ensuring the safety, quality, and efficacy of the final product. The financial opportunity within the biopharmaceutical market has been analyzed across the following segments:
- Type of Filtration System
- Depth Filtration System
- Tangential Flow Filtration Systems
- Membrane Filtration System
- Other Filtration Systems
- Type of Filter (based on use)
- Disposable / Single-use Filters
- Reusable / Multi-use Filters
- Type of Assembly
- Capsules
- Cartridges
- Others
- Type of Drug Product
- Antibodies
- Vaccines
- Recombinant Proteins
- Cell Therapies
- Gene Therapies
- Oligonucleotides
- Others
- Company Size
- Small / Mid-sized
- Large
- Key Geographical Regions
- North America
- Europe
- Asia-Pacific
Rest of the World
Table of Content
- PREFACE
1.1. Chapter Overview
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
- EXECUTIVE SUMMARY
- INTRODUCTION
3.1. Chapter Overview
3.2. Filtration Systems
3.3. Types of Filtration Systems
3.4. Steps for Sterile Filtration for Bioprocessing
3.5. Factors Affecting Sterile Filtration
3.6. Advantages of Biopharmaceutical Filtration Systems
3.7. Challenges Associated with Biopharmaceutical Filtration Systems
3.8. Applications of Biopharmaceutical Filtration Systems
3.9. Concluding Remarks
- BIOPHARMACEUTICAL FILTRATION: MARKET LANDSCAPE
4.1. Chapter Overview
4.2. List of Biopharmaceutical Filtration System Suppliers
- COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2 Methodology and Key Parameters
5.3. Biopharmaceutical Filtration System Suppliers: Company Competitiveness Analysis
5.3.1. Players Headquartered in North America
5.3.2. Players Headquartered in Europe
5.3.3. Players Headquartered in Asia-Pacific and Rest of the World
- SUPPLIERS HEADQUARTERED IN NORTH AMERICA: COMPANY PROFILES
6.1. Chapter Overview
6.2. Corning
6.3. Pall Corporation
6.4. Parker Hannifin
6.5. Thermo Fisher Scientific
- SUPPLIERS HEADQUARTERED IN EUROPE AND ASIA-PACIFIC: COMPANY PROFILES
7.1. Chapter Overview
7.2. Merck
7.2.1. Company Overview
7.2.2. Financial Information
7.2.3. Product Portfolio
7.2.4. Recent Developments and Future Outlook
7.3. Sartorius
7.4. Asahi Kasei
7.4.1. Company Overview
7.5. Cobetter Filtration
- RECENT DEVELOPMENTS
8.1. Chapter Overview
8.2. Scope and Methodology
8.3 Biopharmaceutical Filtration: Mergers and Acquisitions
- GLOBAL EVENTS ANALYSIS
9.1 Chapter Overview
9.2. List of Global Events
- BIOPHARMACEUTICAL FILTRATION: MARKET FORECAST AND OPPORTUNITY ANALYSIS
10.1. Chapter Overview
10.2. Key Assumptions and Methodology
10.3. Biopharmaceutical Filtration Market, 2023-2035
- CONCLUSION
- EXECUTIVE INSIGHTS
- APPENDIX 1: TABULATED DATA
- APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/global-filtration-market.html
Learn from experts: do you know about these emerging industry trends?
Deep Learning-based Interoperability: Advanced Neural Networks Mimicking the Human Brain
Novel Cell Cytometers: Need of the Hour
Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
